Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
56.02 USD | -0.06% | +0.48% | +24.74% |
Apr. 12 | Zacks Investment Research Downgrades Catalent to Underperform From Neutral, Price Target is $48 | MT |
Apr. 08 | Sector Update: Health Care Stocks Decline Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.74% | 10.14B | |
+27.87% | 659B | |
+27.68% | 557B | |
-4.42% | 359B | |
+16.35% | 322B | |
+9.01% | 297B | |
+6.30% | 215B | |
+4.80% | 210B | |
-6.05% | 200B | |
-8.77% | 149B |
- Stock Market
- Equities
- CTLT Stock
- News Catalent, Inc.
- Catalent Fiscal Q2 Adjusted EPS, Revenue Rise; Full-Year 2022 Guidance Lifted -- Shares Gain Pre-Bell